Eintrag weiter verarbeiten
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia
Gespeichert in:
Zeitschriftentitel: | Psychiatric Services |
---|---|
Personen und Körperschaften: | , , |
In: | Psychiatric Services, 69, 2018, 1, S. 12-14 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Psychiatric Association Publishing
|
Schlagwörter: |
author_facet |
Predmore, Zachary Mattke, Soeren Horvitz-Lennon, Marcela Predmore, Zachary Mattke, Soeren Horvitz-Lennon, Marcela |
---|---|
author |
Predmore, Zachary Mattke, Soeren Horvitz-Lennon, Marcela |
spellingShingle |
Predmore, Zachary Mattke, Soeren Horvitz-Lennon, Marcela Psychiatric Services Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia Psychiatry and Mental health |
author_sort |
predmore, zachary |
spelling |
Predmore, Zachary Mattke, Soeren Horvitz-Lennon, Marcela 1075-2730 1557-9700 American Psychiatric Association Publishing Psychiatry and Mental health http://dx.doi.org/10.1176/appi.ps.201700398 Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia Psychiatric Services |
doi_str_mv |
10.1176/appi.ps.201700398 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Psychologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ni9hcHBpLnBzLjIwMTcwMDM5OA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ni9hcHBpLnBzLjIwMTcwMDM5OA |
institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
imprint |
American Psychiatric Association Publishing, 2018 |
imprint_str_mv |
American Psychiatric Association Publishing, 2018 |
issn |
1075-2730 1557-9700 |
issn_str_mv |
1075-2730 1557-9700 |
language |
English |
mega_collection |
American Psychiatric Association Publishing (CrossRef) |
match_str |
predmore2018potentialbenefitstopatientsandpayersfromincreasedmeasurementofantipsychoticplasmalevelsinthemanagementofschizophrenia |
publishDateSort |
2018 |
publisher |
American Psychiatric Association Publishing |
recordtype |
ai |
record_format |
ai |
series |
Psychiatric Services |
source_id |
49 |
title |
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_unstemmed |
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_full |
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_fullStr |
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_full_unstemmed |
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_short |
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_sort |
potential benefits to patients and payers from increased measurement of antipsychotic plasma levels in the management of schizophrenia |
topic |
Psychiatry and Mental health |
url |
http://dx.doi.org/10.1176/appi.ps.201700398 |
publishDate |
2018 |
physical |
12-14 |
description |
|
container_issue |
1 |
container_start_page |
12 |
container_title |
Psychiatric Services |
container_volume |
69 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792346354265096198 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T17:37:57.54Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Potential+Benefits+to+Patients+and+Payers+From+Increased+Measurement+of+Antipsychotic+Plasma+Levels+in+the+Management+of+Schizophrenia&rft.date=2018-01-01&genre=article&issn=1557-9700&volume=69&issue=1&spage=12&epage=14&pages=12-14&jtitle=Psychiatric+Services&atitle=Potential+Benefits+to+Patients+and+Payers+From+Increased+Measurement+of+Antipsychotic+Plasma+Levels+in+the+Management+of+Schizophrenia&aulast=Horvitz-Lennon&aufirst=Marcela&rft_id=info%3Adoi%2F10.1176%2Fappi.ps.201700398&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792346354265096198 |
author | Predmore, Zachary, Mattke, Soeren, Horvitz-Lennon, Marcela |
author_facet | Predmore, Zachary, Mattke, Soeren, Horvitz-Lennon, Marcela, Predmore, Zachary, Mattke, Soeren, Horvitz-Lennon, Marcela |
author_sort | predmore, zachary |
container_issue | 1 |
container_start_page | 12 |
container_title | Psychiatric Services |
container_volume | 69 |
description | |
doi_str_mv | 10.1176/appi.ps.201700398 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Psychologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ni9hcHBpLnBzLjIwMTcwMDM5OA |
imprint | American Psychiatric Association Publishing, 2018 |
imprint_str_mv | American Psychiatric Association Publishing, 2018 |
institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
issn | 1075-2730, 1557-9700 |
issn_str_mv | 1075-2730, 1557-9700 |
language | English |
last_indexed | 2024-03-01T17:37:57.54Z |
match_str | predmore2018potentialbenefitstopatientsandpayersfromincreasedmeasurementofantipsychoticplasmalevelsinthemanagementofschizophrenia |
mega_collection | American Psychiatric Association Publishing (CrossRef) |
physical | 12-14 |
publishDate | 2018 |
publishDateSort | 2018 |
publisher | American Psychiatric Association Publishing |
record_format | ai |
recordtype | ai |
series | Psychiatric Services |
source_id | 49 |
spelling | Predmore, Zachary Mattke, Soeren Horvitz-Lennon, Marcela 1075-2730 1557-9700 American Psychiatric Association Publishing Psychiatry and Mental health http://dx.doi.org/10.1176/appi.ps.201700398 Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia Psychiatric Services |
spellingShingle | Predmore, Zachary, Mattke, Soeren, Horvitz-Lennon, Marcela, Psychiatric Services, Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia, Psychiatry and Mental health |
title | Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_full | Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_fullStr | Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_full_unstemmed | Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_short | Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
title_sort | potential benefits to patients and payers from increased measurement of antipsychotic plasma levels in the management of schizophrenia |
title_unstemmed | Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia |
topic | Psychiatry and Mental health |
url | http://dx.doi.org/10.1176/appi.ps.201700398 |